Domestic equity bourses in the coming week will be guided by Q1 GDP print, infrastructure output data for July and monthly auto sales numbers, which together will give an indication about the health of the economy, analysts said. During this data heavy week, the investor focus will also remain on global market trends and COVID-19 updates like the number of infection cases and news related to the progress of vaccines.
"This week, participants will be closely eyeing auto sales number and GDP data for cues on how the economy is progressing. Besides, monsoon progress and news updates related to COVID-19 would also be on their radar," said Ajit Mishra, VP-Research, Religare Broking Ltd.
The Indian market last week, ended August 28, showed a stellar performance, with the BSE Sensex gaining 1,032 points and the NSE Nifty adding 276 points -- both indices rising 2 percent each.
The National Statistical Office (NSO) will release the infrastructure output data for July and the GDP number for the April-June quarter on Monday.
Various rating agencies and industry experts have been forecasting GDP contraction for the first quarter as the economy came under a severe pressure in the wake of the coronavirus outbreak and ensuing lockdowns during this period.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
As other macro data are concerned, auto companies will announce their monthly sales data for August this week and PMI data for manufacturing and services sector are also.
"Market is expected to continue the momentum. There could be a slight consolidation in the markets, when profit-booking emerges, but it is not likely to be a long drawn out correction," Vinod Nair, Head of Research at Geojit Financial Services, said.
Samco Securities Senior Research Analyst Nirali Shah said, "For the week ahead, markets may watch out for August auto sales numbers from India Inc which might broadly act as a proxy for the health of our ailing economy, to an extent."
Experts are of the view that movement in rupee/USD, trend in foreign fund and crude oil would also be monitored by market participants.Meanwhile, India's COVID-19 case tally crossed 35 lakh mark with a spike of nearly 79,000 new cases in a day on Saturday. The number of deaths has topped 63,000, as per official data.